Dual variable domain immunoglobulins and uses thereof

Disclosed is a binding protein comprising first and second polypeptide chains, each independently comprising - VD1-(X1)n-VD2-C-(X2)n, wherein - VD1 is a first variable domain; - VD2 is a second variable domain; - C is a constant domain; - X1 is a linker; - X2 is an Fc region; - n is 0 or 1; - wherei...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HARRIS MARIA C, GU JIJIE, MCPHERSON MICHAEL J, ISAKSON PETER C, SALFELD JOCHEN G, LIU JUNJIAN, GHAYUR TARIQ
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HARRIS MARIA C
GU JIJIE
MCPHERSON MICHAEL J
ISAKSON PETER C
SALFELD JOCHEN G
LIU JUNJIAN
GHAYUR TARIQ
description Disclosed is a binding protein comprising first and second polypeptide chains, each independently comprising - VD1-(X1)n-VD2-C-(X2)n, wherein - VD1 is a first variable domain; - VD2 is a second variable domain; - C is a constant domain; - X1 is a linker; - X2 is an Fc region; - n is 0 or 1; - wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding TNF, wherein the variable domains that form a functional target binding site for TNF comprise CDRs 1-3 from SEQ ID NO: 40 and CDRs 1-3 from SEQ ID NO: 41, wherein SEQ ID NOs: 40 and 41 are disclosed within the specification. Also disclosed is the use of the above-described binding protein in the manufacture of a medicament for treating a subject for a disease or a disorder.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ620267A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ620267A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ620267A3</originalsourceid><addsrcrecordid>eNrjZDB1KU3MUShLLMpMTMpJVUjJz03MzFPIzM0tzctPz8lPKs3JzCtWSMxLUSgtTi1WKMlILUrNT-NhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfF-UWZGBkZm5o7GBBUAAH2CLFo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Dual variable domain immunoglobulins and uses thereof</title><source>esp@cenet</source><creator>HARRIS MARIA C ; GU JIJIE ; MCPHERSON MICHAEL J ; ISAKSON PETER C ; SALFELD JOCHEN G ; LIU JUNJIAN ; GHAYUR TARIQ</creator><creatorcontrib>HARRIS MARIA C ; GU JIJIE ; MCPHERSON MICHAEL J ; ISAKSON PETER C ; SALFELD JOCHEN G ; LIU JUNJIAN ; GHAYUR TARIQ</creatorcontrib><description>Disclosed is a binding protein comprising first and second polypeptide chains, each independently comprising - VD1-(X1)n-VD2-C-(X2)n, wherein - VD1 is a first variable domain; - VD2 is a second variable domain; - C is a constant domain; - X1 is a linker; - X2 is an Fc region; - n is 0 or 1; - wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding TNF, wherein the variable domains that form a functional target binding site for TNF comprise CDRs 1-3 from SEQ ID NO: 40 and CDRs 1-3 from SEQ ID NO: 41, wherein SEQ ID NOs: 40 and 41 are disclosed within the specification. Also disclosed is the use of the above-described binding protein in the manufacture of a medicament for treating a subject for a disease or a disorder.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150626&amp;DB=EPODOC&amp;CC=NZ&amp;NR=620267A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150626&amp;DB=EPODOC&amp;CC=NZ&amp;NR=620267A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HARRIS MARIA C</creatorcontrib><creatorcontrib>GU JIJIE</creatorcontrib><creatorcontrib>MCPHERSON MICHAEL J</creatorcontrib><creatorcontrib>ISAKSON PETER C</creatorcontrib><creatorcontrib>SALFELD JOCHEN G</creatorcontrib><creatorcontrib>LIU JUNJIAN</creatorcontrib><creatorcontrib>GHAYUR TARIQ</creatorcontrib><title>Dual variable domain immunoglobulins and uses thereof</title><description>Disclosed is a binding protein comprising first and second polypeptide chains, each independently comprising - VD1-(X1)n-VD2-C-(X2)n, wherein - VD1 is a first variable domain; - VD2 is a second variable domain; - C is a constant domain; - X1 is a linker; - X2 is an Fc region; - n is 0 or 1; - wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding TNF, wherein the variable domains that form a functional target binding site for TNF comprise CDRs 1-3 from SEQ ID NO: 40 and CDRs 1-3 from SEQ ID NO: 41, wherein SEQ ID NOs: 40 and 41 are disclosed within the specification. Also disclosed is the use of the above-described binding protein in the manufacture of a medicament for treating a subject for a disease or a disorder.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB1KU3MUShLLMpMTMpJVUjJz03MzFPIzM0tzctPz8lPKs3JzCtWSMxLUSgtTi1WKMlILUrNT-NhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfF-UWZGBkZm5o7GBBUAAH2CLFo</recordid><startdate>20150626</startdate><enddate>20150626</enddate><creator>HARRIS MARIA C</creator><creator>GU JIJIE</creator><creator>MCPHERSON MICHAEL J</creator><creator>ISAKSON PETER C</creator><creator>SALFELD JOCHEN G</creator><creator>LIU JUNJIAN</creator><creator>GHAYUR TARIQ</creator><scope>EVB</scope></search><sort><creationdate>20150626</creationdate><title>Dual variable domain immunoglobulins and uses thereof</title><author>HARRIS MARIA C ; GU JIJIE ; MCPHERSON MICHAEL J ; ISAKSON PETER C ; SALFELD JOCHEN G ; LIU JUNJIAN ; GHAYUR TARIQ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ620267A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HARRIS MARIA C</creatorcontrib><creatorcontrib>GU JIJIE</creatorcontrib><creatorcontrib>MCPHERSON MICHAEL J</creatorcontrib><creatorcontrib>ISAKSON PETER C</creatorcontrib><creatorcontrib>SALFELD JOCHEN G</creatorcontrib><creatorcontrib>LIU JUNJIAN</creatorcontrib><creatorcontrib>GHAYUR TARIQ</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HARRIS MARIA C</au><au>GU JIJIE</au><au>MCPHERSON MICHAEL J</au><au>ISAKSON PETER C</au><au>SALFELD JOCHEN G</au><au>LIU JUNJIAN</au><au>GHAYUR TARIQ</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Dual variable domain immunoglobulins and uses thereof</title><date>2015-06-26</date><risdate>2015</risdate><abstract>Disclosed is a binding protein comprising first and second polypeptide chains, each independently comprising - VD1-(X1)n-VD2-C-(X2)n, wherein - VD1 is a first variable domain; - VD2 is a second variable domain; - C is a constant domain; - X1 is a linker; - X2 is an Fc region; - n is 0 or 1; - wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding TNF, wherein the variable domains that form a functional target binding site for TNF comprise CDRs 1-3 from SEQ ID NO: 40 and CDRs 1-3 from SEQ ID NO: 41, wherein SEQ ID NOs: 40 and 41 are disclosed within the specification. Also disclosed is the use of the above-described binding protein in the manufacture of a medicament for treating a subject for a disease or a disorder.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_NZ620267A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Dual variable domain immunoglobulins and uses thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A41%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HARRIS%20MARIA%20C&rft.date=2015-06-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ620267A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true